AI predicting brain cancer relapse is a groundbreaking advancement in the field of pediatric oncology, offering a new beacon of hope for patients and their families.Recent research from Mass General Brigham reveals that an artificial intelligence tool can outperform traditional methods in assessing the risk of relapse among children suffering from gliomas.